Lime Chemicals（507759）株式概要ライムケミカルズ社はインドで沈殿炭酸カルシウムと被覆炭酸カルシウムを製造販売している。 詳細507759 ファンダメンタル分析スノーフレーク・スコア評価0/6将来の成長0/6過去の実績0/6財務の健全性2/6配当金0/6リスク分析負債は営業キャッシュフローで十分にカバーされていない 過去5年間で収益は年間55.2%減少しました。 Indian市場と比較して、過去 3 か月間の株価の変動が非常に大きい収益が 100 万ドル未満 ( ₹65M )+1 さらなるリスクすべてのリスクチェックを見る507759 Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair Value₹Current Price₹14.98190.9% 割高 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture-11m509m2016201920222025202620282031Revenue ₹20.9mEarnings ₹2.0mAdvancedSet Fair ValueView all narrativesLime Chemicals Limited 競合他社Sreechem ResinsSymbol: BSE:514248Market cap: ₹144.9mAhimsa IndustriesSymbol: NSEI:AHIMSAMarket cap: ₹135.2mLink Pharma ChemSymbol: BSE:524748Market cap: ₹124.3mKuwer IndustriesSymbol: BSE:530421Market cap: ₹116.1m価格と性能株価の高値、安値、推移の概要Lime Chemicals過去の株価現在の株価₹14.9852週高値₹19.7352週安値₹11.15ベータ0.401ヶ月の変化9.34%3ヶ月変化3.10%1年変化-13.91%3年間の変化-32.70%5年間の変化-49.56%IPOからの変化49.80%最新ニュースお知らせ • May 22Lime Chemicals Limited to Report Q4, 2026 Results on May 30, 2026Lime Chemicals Limited announced that they will report Q4, 2026 results at 3:30 PM, Indian Standard Time on May 30, 2026Reported Earnings • Feb 16Third quarter 2026 earnings released: ₹0.14 loss per share (vs ₹0.09 profit in 3Q 2025)Third quarter 2026 results: ₹0.14 loss per share (down from ₹0.09 profit in 3Q 2025). Revenue: ₹15.7m (down 40% from 3Q 2025). Net loss: ₹797.0k (down 226% from profit in 3Q 2025). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 86 percentage points per year, which is a significant difference in performance.お知らせ • Feb 03Lime Chemicals Limited to Report Q3, 2026 Results on Feb 14, 2026Lime Chemicals Limited announced that they will report Q3, 2026 results at 3:30 PM, Indian Standard Time on Feb 14, 2026Reported Earnings • Nov 16Second quarter 2026 earnings released: ₹0.25 loss per share (vs ₹0.11 loss in 2Q 2025)Second quarter 2026 results: ₹0.25 loss per share (further deteriorated from ₹0.11 loss in 2Q 2025). Revenue: ₹14.9m (down 38% from 2Q 2025). Net loss: ₹1.59m (loss widened 195% from 2Q 2025). Over the last 3 years on average, earnings per share has fallen by 60% per year but the company’s share price has only fallen by 18% per year, which means it has not declined as severely as earnings.お知らせ • Nov 08Lime Chemicals Limited to Report Q2, 2026 Results on Nov 14, 2025Lime Chemicals Limited announced that they will report Q2, 2026 results on Nov 14, 2025お知らせ • Sep 08Lime Chemicals Limited, Annual General Meeting, Sep 30, 2025Lime Chemicals Limited, Annual General Meeting, Sep 30, 2025.最新情報をもっと見るRecent updatesお知らせ • May 22Lime Chemicals Limited to Report Q4, 2026 Results on May 30, 2026Lime Chemicals Limited announced that they will report Q4, 2026 results at 3:30 PM, Indian Standard Time on May 30, 2026Reported Earnings • Feb 16Third quarter 2026 earnings released: ₹0.14 loss per share (vs ₹0.09 profit in 3Q 2025)Third quarter 2026 results: ₹0.14 loss per share (down from ₹0.09 profit in 3Q 2025). Revenue: ₹15.7m (down 40% from 3Q 2025). Net loss: ₹797.0k (down 226% from profit in 3Q 2025). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 86 percentage points per year, which is a significant difference in performance.お知らせ • Feb 03Lime Chemicals Limited to Report Q3, 2026 Results on Feb 14, 2026Lime Chemicals Limited announced that they will report Q3, 2026 results at 3:30 PM, Indian Standard Time on Feb 14, 2026Reported Earnings • Nov 16Second quarter 2026 earnings released: ₹0.25 loss per share (vs ₹0.11 loss in 2Q 2025)Second quarter 2026 results: ₹0.25 loss per share (further deteriorated from ₹0.11 loss in 2Q 2025). Revenue: ₹14.9m (down 38% from 2Q 2025). Net loss: ₹1.59m (loss widened 195% from 2Q 2025). Over the last 3 years on average, earnings per share has fallen by 60% per year but the company’s share price has only fallen by 18% per year, which means it has not declined as severely as earnings.お知らせ • Nov 08Lime Chemicals Limited to Report Q2, 2026 Results on Nov 14, 2025Lime Chemicals Limited announced that they will report Q2, 2026 results on Nov 14, 2025お知らせ • Sep 08Lime Chemicals Limited, Annual General Meeting, Sep 30, 2025Lime Chemicals Limited, Annual General Meeting, Sep 30, 2025.New Risk • Aug 15New major risk - Revenue sizeThe company makes less than US$1m in revenue. Total revenue: ₹87m (US$989k) This is considered a major risk. Companies with a small amount of revenue are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Share price has been highly volatile over the past 3 months (11% average weekly change). Revenue is less than US$1m (₹87m revenue, or US$989k). Market cap is less than US$10m (₹95.0m market cap, or US$1.09m).Valuation Update With 7 Day Price Move • Aug 14Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to ₹14.60, the stock trades at a trailing P/E ratio of 42.9x. Average trailing P/E is 26x in the Chemicals industry in India. Total loss to shareholders of 38% over the past three years.New Risk • Jul 21New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 8.4% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Share price has been highly volatile over the past 3 months (8.4% average weekly change). Market cap is less than US$10m (₹99.9m market cap, or US$1.16m). Minor Risk Revenue is less than US$5m (₹97m revenue, or US$1.1m).Reported Earnings • Jun 02Full year 2025 earnings released: EPS: ₹0.31 (vs ₹0.76 loss in FY 2024)Full year 2025 results: EPS: ₹0.31 (up from ₹0.76 loss in FY 2024). Revenue: ₹102.8m (down 1.7% from FY 2024). Net income: ₹2.21m (up ₹7.13m from FY 2024). Profit margin: 2.2% (up from net loss in FY 2024). The move to profitability was driven by lower expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 66 percentage points per year, which is a significant difference in performance.お知らせ • May 17Lime Chemicals Limited to Report Q4, 2025 Results on May 30, 2025Lime Chemicals Limited announced that they will report Q4, 2025 results on May 30, 2025New Risk • Apr 02New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (6.4% operating cash flow to total debt). Market cap is less than US$10m (₹106.0m market cap, or US$1.24m). Minor Risks Share price has been volatile over the past 3 months (8.8% average weekly change). Revenue is less than US$5m (₹104m revenue, or US$1.2m).Buy Or Sell Opportunity • Feb 17Now 20% undervalued after recent price dropOver the last 90 days, the stock has fallen 28% to ₹20.00. The fair value is estimated to be ₹25.02, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 16% over the last 3 years. Meanwhile, the company has become profitable.Reported Earnings • Feb 15Third quarter 2025 earnings released: EPS: ₹0.09 (vs ₹0.11 loss in 3Q 2024)Third quarter 2025 results: EPS: ₹0.09 (up from ₹0.11 loss in 3Q 2024). Revenue: ₹26.5m (up 2.0% from 3Q 2024). Net income: ₹635.0k (up ₹1.28m from 3Q 2024). Profit margin: 2.4% (up from net loss in 3Q 2024). The move to profitability was primarily driven by lower expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 86 percentage points per year, which is a significant difference in performance.お知らせ • Feb 03Lime Chemicals Limited to Report Q3, 2025 Results on Feb 14, 2025Lime Chemicals Limited announced that they will report Q3, 2025 results on Feb 14, 2025Buy Or Sell Opportunity • Nov 25Now 23% undervalued after recent price dropOver the last 90 days, the stock has fallen 3.1% to ₹25.55. The fair value is estimated to be ₹32.99, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 14% over the last 3 years. Meanwhile, the company became loss making.New Risk • Nov 23New major risk - Revenue and earnings growthEarnings have declined by 4.5% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (6.4% operating cash flow to total debt). Share price has been highly volatile over the past 3 months (9.4% average weekly change). Earnings have declined by 4.5% per year over the past 5 years. Market cap is less than US$10m (₹174.9m market cap, or US$2.07m). Minor Risk Revenue is less than US$5m (₹104m revenue, or US$1.2m).お知らせ • Nov 02Lime Chemicals Limited to Report Q2, 2025 Results on Nov 14, 2024Lime Chemicals Limited announced that they will report Q2, 2025 results on Nov 14, 2024お知らせ • Aug 30Lime Chemicals Limited, Annual General Meeting, Sep 30, 2024Lime Chemicals Limited, Annual General Meeting, Sep 30, 2024.Reported Earnings • Aug 15First quarter 2025 earnings released: EPS: ₹0.24 (vs ₹0.33 loss in 1Q 2024)First quarter 2025 results: EPS: ₹0.24 (up from ₹0.33 loss in 1Q 2024). Revenue: ₹30.8m (down 5.2% from 1Q 2024). Net income: ₹1.53m (up ₹3.63m from 1Q 2024). Profit margin: 5.0% (up from net loss in 1Q 2024). The move to profitability was driven by lower expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 90 percentage points per year, which is a significant difference in performance.お知らせ • Aug 02Lime Chemicals Limited to Report Q1, 2025 Results on Aug 14, 2024Lime Chemicals Limited announced that they will report Q1, 2025 results on Aug 14, 2024Buy Or Sell Opportunity • Jul 04Now 15% undervaluedThe stock has been flat over the last 90 days, currently trading at ₹29.12. The fair value is estimated to be ₹34.16, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 16% over the last 3 years. Meanwhile, the company became loss making.Buy Or Sell Opportunity • Jun 19Now 24% undervalued after recent price dropOver the last 90 days, the stock has fallen 9.0% to ₹26.14. The fair value is estimated to be ₹34.28, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 16% over the last 3 years. Meanwhile, the company became loss making.Buy Or Sell Opportunity • Jun 11Now 22% undervalued after recent price dropOver the last 90 days, the stock has fallen 7.9% to ₹26.26. The fair value is estimated to be ₹33.76, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 16% over the last 3 years. Meanwhile, the company became loss making.Reported Earnings • Jun 04Full year 2024 earnings released: ₹0.76 loss per share (vs ₹4.24 profit in FY 2023)Full year 2024 results: ₹0.76 loss per share (down from ₹4.24 profit in FY 2023). Revenue: ₹108.5m (down 30% from FY 2023). Net loss: ₹4.92m (down 118% from profit in FY 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 62 percentage points per year, which is a significant difference in performance.お知らせ • May 20Lime Chemicals Limited to Report Q4, 2024 Results on May 30, 2024Lime Chemicals Limited announced that they will report Q4, 2024 results on May 30, 2024New Risk • Apr 18New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Market cap is less than US$10m (₹178.2m market cap, or US$2.13m). Minor Risks Share price has been volatile over the past 3 months (8.5% average weekly change). Revenue is less than US$5m (₹115m revenue, or US$1.4m).Reported Earnings • Feb 16Third quarter 2024 earnings released: ₹0.11 loss per share (vs ₹4.38 profit in 3Q 2023)Third quarter 2024 results: ₹0.11 loss per share (down from ₹4.38 profit in 3Q 2023). Revenue: ₹25.9m (down 30% from 3Q 2023). Net loss: ₹645.0k (down 102% from profit in 3Q 2023). Over the last 3 years on average, earnings per share has fallen by 43% per year but the company’s share price has increased by 15% per year, which means it is well ahead of earnings.New Risk • Nov 12New major risk - Earnings qualityThe company has a high level of non-cash earnings. Accrual ratio: 88% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Share price has been highly volatile over the past 3 months (11% average weekly change). High level of non-cash earnings (88% accrual ratio). Market cap is less than US$10m (₹172.4m market cap, or US$2.07m). Minor Risk Revenue is less than US$5m (₹126m revenue, or US$1.5m).Reported Earnings • Nov 12Second quarter 2024 earnings released: ₹0.18 loss per share (vs ₹0.06 loss in 2Q 2023)Second quarter 2024 results: ₹0.18 loss per share (further deteriorated from ₹0.06 loss in 2Q 2023). Revenue: ₹22.9m (down 48% from 2Q 2023). Net loss: ₹1.09m (loss widened 240% from 2Q 2023). Over the last 3 years on average, earnings per share has fallen by 19% per year but the company’s share price has increased by 11% per year, which means it is well ahead of earnings.お知らせ • Nov 04Lime Chemicals Limited to Report Q2, 2024 Results on Nov 11, 2023Lime Chemicals Limited announced that they will report Q2, 2024 results at 3:30 PM, Indian Standard Time on Nov 11, 2023Valuation Update With 7 Day Price Move • Oct 05Investor sentiment improves as stock rises 18%After last week's 18% share price gain to ₹27.99, the stock trades at a trailing P/E ratio of 7.4x. Average trailing P/E is 27x in the Chemicals industry in India. Total returns to shareholders of 99% over the past three years.お知らせ • Sep 07Lime Chemicals Limited, Annual General Meeting, Sep 30, 2023Lime Chemicals Limited, Annual General Meeting, Sep 30, 2023, at 11:30 Indian Standard Time. Location: K Star Hotel, Rajiv Gandhi Road, Sector-11, C.B.D. Belapur (East) Navi Mumbai Maharashtra India Agenda: To receive and adopt the Profit and Loss Account for the year ended on 31st March, 2023 and the Balance Sheet as on that date and the reports of Auditors and Directors thereof; to consider directorate reelections; to appoint statutory auditors of the Company and fix their remuneration; to consider Ratification of remuneration of Cost Auditors; and to consider other matters.Reported Earnings • Aug 15First quarter 2024 earnings released: ₹0.33 loss per share (vs ₹0.12 profit in 1Q 2023)First quarter 2024 results: ₹0.33 loss per share (down from ₹0.12 profit in 1Q 2023). Revenue: ₹33.5m (down 17% from 1Q 2023). Net loss: ₹2.10m (down 361% from profit in 1Q 2023). Over the last 3 years on average, earnings per share has fallen by 1% per year whereas the company’s share price has remained flat.お知らせ • Aug 04Lime Chemicals Limited to Report Q1, 2024 Results on Aug 14, 2023Lime Chemicals Limited announced that they will report Q1, 2024 results on Aug 14, 2023Reported Earnings • Jun 01Full year 2023 earnings released: EPS: ₹4.24 (vs ₹15.06 in FY 2022)Full year 2023 results: EPS: ₹4.24 (down from ₹15.06 in FY 2022). Revenue: ₹156.0m (up 11% from FY 2022). Net income: ₹27.6m (down 72% from FY 2022). Profit margin: 18% (down from 70% in FY 2022). Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has remained flat, which means it is significantly lagging earnings.Valuation Update With 7 Day Price Move • Apr 05Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹24.06, the stock trades at a trailing P/E ratio of 8.3x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 59% over the past three years.お知らせ • Jan 24Lime Chemicals Limited to Report Q3, 2023 Results on Feb 14, 2023Lime Chemicals Limited announced that they will report Q3, 2023 results at 12:15 PM, Indian Standard Time on Feb 14, 2023お知らせ • Sep 30Lime Chemicals Limited Appoints Pramod N. Manjrekar as Non-Executive Independent Director52nd Annual General Meeting of Lime Chemicals Limited held on 30" September 2022. announced Appointment of Mr. Pramod N. Manjrekar, as non-executive Independent Director.Reported Earnings • Sep 10Full year 2022 earnings released: EPS: ₹15.06 (vs ₹0.21 in FY 2021)Full year 2022 results: EPS: ₹15.06 (up from ₹0.21 in FY 2021). Revenue: ₹140.6m (down 37% from FY 2021). Net income: ₹98.0m (up ₹96.6m from FY 2021). Profit margin: 70% (up from 0.6% in FY 2021). Over the last 3 years on average, earnings per share has increased by 93% per year but the company’s share price has only increased by 10% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Sep 06Investor sentiment improved over the past weekAfter last week's 17% share price gain to ₹30.90, the stock trades at a trailing P/E ratio of 2.1x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 37% over the past three years.お知らせ • Aug 18+ 1 more updateLime Chemicals Limited Announces Executive ChangesLime Chemicals Limited announced that on the recommendation of the Nomination & Remuneration Committee, the Board of Directors of the Company at their meeting held August 17, 2022, have approved the appointments of Mr. Amol V. Patil as Chief Financial Officer. Mr. Amol V. Patil, appointed as Chief Financial Officer with effect from August 17, 2022, in place of Mr. Firoj Ladhani, who retired on 16 August 2022. He is a Key Managerial Personnel of the Company pursuant to Section 203 of the Companies Act, 2013. Mr. Amol V. Patil is B.A. & MBA and working with the Company for the past 3 years as Key Accounts Manager. He has experience in managing Customers & Vendors & also handling Accounts Receivable &tracking cash flow and Financials Planning Of the Company.お知らせ • Aug 05Lime Chemicals Limited to Report Q1, 2023 Results on Aug 13, 2022Lime Chemicals Limited announced that they will report Q1, 2023 results on Aug 13, 2022お知らせ • Jun 03Lime Chemicals Limited Announces Resignation of Ms. Runel Saxena as Company Secretary/Compliance OfficerLime Chemicals Limited informed that Ms. Runel Saxena, the Company Secretary and Compliance Officer of the Company has resigned from the close of working hours of May 31, 2022. The Company is in the process of appointing new Company Secretary.Valuation Update With 7 Day Price Move • Mar 10Investor sentiment improved over the past weekAfter last week's 19% share price gain to ₹32.40, the stock trades at a trailing P/E ratio of 2x. Average trailing P/E is 18x in the Chemicals industry in India. Total loss to shareholders of 6.5% over the past three years.お知らせ • Feb 02Lime Chemicals Limited to Report Q3, 2022 Results on Feb 14, 2022Lime Chemicals Limited announced that they will report Q3, 2022 results on Feb 14, 2022Valuation Update With 7 Day Price Move • Oct 04Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₹33.25, the stock trades at a trailing P/E ratio of 2x. Average trailing P/E is 19x in the Chemicals industry in India. Total loss to shareholders of 43% over the past three years.Recent Insider Transactions • Aug 23Non-Executive Non Independent Director recently bought ₹1.6m worth of stockOn the 20th of August, Shahnaz Dawoodani bought around 56k shares on-market at roughly ₹27.89 per share. This was the largest purchase by an insider in the last 3 months. This was the only on-market transaction from insiders over the last 12 months.Reported Earnings • Aug 18First quarter 2022 earnings released: EPS ₹16.75 (vs ₹0.71 in 1Q 2021)First quarter 2022 results: Revenue: ₹24.2m (down 57% from 1Q 2021). Net income: ₹109.0m (up ₹104.4m from 1Q 2021). Over the last 3 years on average, earnings per share has fallen by 42% per year but the company’s share price has only fallen by 29% per year, which means it has not declined as severely as earnings.Reported Earnings • Jul 06Full year 2021 earnings released: EPS ₹0.21 (vs ₹0.49 loss in FY 2020)The company reported a decent full year result with improved earnings and profit margins, although revenues were weaker. Full year 2021 results: Revenue: ₹246.2m (down 22% from FY 2020). Net income: ₹1.35m (up ₹4.53m from FY 2020). Profit margin: 0.5% (up from net loss in FY 2020). The move to profitability was driven by lower expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 77 percentage points per year, which is a significant difference in performance.Valuation Update With 7 Day Price Move • May 28Investor sentiment improved over the past weekAfter last week's 18% share price gain to ₹25.85, the stock trades at a trailing P/E ratio of 11.5x. Average trailing P/E is 20x in the Chemicals industry in India. Total loss to shareholders of 74% over the past three years.Reported Earnings • Feb 14Third quarter 2021 earnings released: ₹0.04 loss per share (vs ₹0.063 loss in 3Q 2020)The company reported a decent third quarter result with reduced losses and improved control over expenses, although revenues were weaker. Third quarter 2021 results: Revenue: ₹53.6m (down 27% from 3Q 2020). Net loss: ₹244.0k (loss narrowed 41% from 3Q 2020). Over the last 3 years on average, earnings per share has fallen by 98% per year but the company’s share price has only fallen by 34% per year, which means it has not declined as severely as earnings.お知らせ • Feb 06Lime Chemicals Limited to Report Q3, 2021 Results on Feb 13, 2021Lime Chemicals Limited announced that they will report Q3, 2021 results on Feb 13, 2021Is New 90 Day High Low • Jan 05New 90-day high: ₹23.55The company is up 67% from its price of ₹14.10 on 07 October 2020. The Indian market is up 20% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 21% over the same period.Valuation Update With 7 Day Price Move • Dec 21Investor sentiment improved over the past weekAfter last week's 15% share price gain to ₹18.20, the stock is trading at a trailing P/E ratio of 8.2x, up from the previous P/E ratio of 7.1x. This compares to an average P/E of 17x in the Chemicals industry in India. Total return to shareholders over the past three years is a loss of 64%.お知らせ • Dec 20Lime Chemicals Limited Announces Resignation of Suresh John as 'Non-Executive Independent Director Designated as Chairman of the Board of Directors of the Company with Effect from 19Th December 2020Lime Chemicals Limited announced that Mr. Suresh John has resigned from 'Non-Executive Independent Director designated as Chairman of the Board of Directors of the Company with effect from 19th December 2020.Is New 90 Day High Low • Oct 23New 90-day high: ₹23.35The company is up 4.0% from its price of ₹22.50 on 24 July 2020. The Indian market is up 7.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 13% over the same period.株主還元507759IN ChemicalsIN 市場7D-9.2%1.8%1.8%1Y-13.9%-2.5%0.4%株主還元を見る業界別リターン: 507759過去 1 年間で-2.5 % の収益を上げたIndian Chemicals業界を下回りました。リターン対市場: 507759は、過去 1 年間で0.4 % のリターンを上げたIndian市場を下回りました。価格変動Is 507759's price volatile compared to industry and market?507759 volatility507759 Average Weekly Movement11.8%Chemicals Industry Average Movement7.4%Market Average Movement7.2%10% most volatile stocks in IN Market10.3%10% least volatile stocks in IN Market4.8%安定した株価: 507759の株価は、 Indian市場と比較して過去 3 か月間で変動しています。時間の経過による変動: 507759の weekly volatility ( 12% ) は過去 1 年間安定していますが、依然としてIndianの株式の 75% よりも高くなっています。会社概要設立従業員CEO（最高経営責任者ウェブサイト1970n/aAhmed Dawoodaniwww.limechem.comライムケミカルズ社はインドで沈殿炭酸カルシウムと被覆炭酸カルシウムを製造販売している。同社は沈殿炭酸カルシウム、活性炭酸カルシウム、粉砕炭酸カルシウム、被覆粉砕炭酸カルシウム、生石灰、ドロマイト、石灰石を提供している。同社の炭酸カルシウムは、歯磨き粉、医薬品、PVC製品、ゴム、プラスチック、ポリマー、ケーブル、皮革、紙、印刷インキ、食品・飲料、化粧品、動物用食品、歯磨剤、シーリング材・マスチック材、塗料など、様々な産業分野で原料として使用されている。同社は1970年に設立され、インドのムンバイに本社を置いている。もっと見るLime Chemicals Limited 基礎のまとめLime Chemicals の収益と売上を時価総額と比較するとどうか。507759 基礎統計学時価総額₹97.44m収益（TTM）-₹1.47m売上高(TTM)₹64.79m1.5xP/Sレシオ-66.5xPER（株価収益率507759 は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計507759 損益計算書（TTM）収益₹64.79m売上原価₹51.85m売上総利益₹12.94mその他の費用₹14.40m収益-₹1.47m直近の収益報告Dec 31, 2025次回決算日May 30, 2026一株当たり利益（EPS）-0.23グロス・マージン19.97%純利益率-2.26%有利子負債／自己資本比率276.5%507759 の長期的なパフォーマンスは？過去の実績と比較を見るView Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/29 22:57終値2026/05/29 00:00収益2025/12/31年間収益2025/03/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Lime Chemicals Limited 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • May 22Lime Chemicals Limited to Report Q4, 2026 Results on May 30, 2026Lime Chemicals Limited announced that they will report Q4, 2026 results at 3:30 PM, Indian Standard Time on May 30, 2026
Reported Earnings • Feb 16Third quarter 2026 earnings released: ₹0.14 loss per share (vs ₹0.09 profit in 3Q 2025)Third quarter 2026 results: ₹0.14 loss per share (down from ₹0.09 profit in 3Q 2025). Revenue: ₹15.7m (down 40% from 3Q 2025). Net loss: ₹797.0k (down 226% from profit in 3Q 2025). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 86 percentage points per year, which is a significant difference in performance.
お知らせ • Feb 03Lime Chemicals Limited to Report Q3, 2026 Results on Feb 14, 2026Lime Chemicals Limited announced that they will report Q3, 2026 results at 3:30 PM, Indian Standard Time on Feb 14, 2026
Reported Earnings • Nov 16Second quarter 2026 earnings released: ₹0.25 loss per share (vs ₹0.11 loss in 2Q 2025)Second quarter 2026 results: ₹0.25 loss per share (further deteriorated from ₹0.11 loss in 2Q 2025). Revenue: ₹14.9m (down 38% from 2Q 2025). Net loss: ₹1.59m (loss widened 195% from 2Q 2025). Over the last 3 years on average, earnings per share has fallen by 60% per year but the company’s share price has only fallen by 18% per year, which means it has not declined as severely as earnings.
お知らせ • Nov 08Lime Chemicals Limited to Report Q2, 2026 Results on Nov 14, 2025Lime Chemicals Limited announced that they will report Q2, 2026 results on Nov 14, 2025
お知らせ • Sep 08Lime Chemicals Limited, Annual General Meeting, Sep 30, 2025Lime Chemicals Limited, Annual General Meeting, Sep 30, 2025.
お知らせ • May 22Lime Chemicals Limited to Report Q4, 2026 Results on May 30, 2026Lime Chemicals Limited announced that they will report Q4, 2026 results at 3:30 PM, Indian Standard Time on May 30, 2026
Reported Earnings • Feb 16Third quarter 2026 earnings released: ₹0.14 loss per share (vs ₹0.09 profit in 3Q 2025)Third quarter 2026 results: ₹0.14 loss per share (down from ₹0.09 profit in 3Q 2025). Revenue: ₹15.7m (down 40% from 3Q 2025). Net loss: ₹797.0k (down 226% from profit in 3Q 2025). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 86 percentage points per year, which is a significant difference in performance.
お知らせ • Feb 03Lime Chemicals Limited to Report Q3, 2026 Results on Feb 14, 2026Lime Chemicals Limited announced that they will report Q3, 2026 results at 3:30 PM, Indian Standard Time on Feb 14, 2026
Reported Earnings • Nov 16Second quarter 2026 earnings released: ₹0.25 loss per share (vs ₹0.11 loss in 2Q 2025)Second quarter 2026 results: ₹0.25 loss per share (further deteriorated from ₹0.11 loss in 2Q 2025). Revenue: ₹14.9m (down 38% from 2Q 2025). Net loss: ₹1.59m (loss widened 195% from 2Q 2025). Over the last 3 years on average, earnings per share has fallen by 60% per year but the company’s share price has only fallen by 18% per year, which means it has not declined as severely as earnings.
お知らせ • Nov 08Lime Chemicals Limited to Report Q2, 2026 Results on Nov 14, 2025Lime Chemicals Limited announced that they will report Q2, 2026 results on Nov 14, 2025
お知らせ • Sep 08Lime Chemicals Limited, Annual General Meeting, Sep 30, 2025Lime Chemicals Limited, Annual General Meeting, Sep 30, 2025.
New Risk • Aug 15New major risk - Revenue sizeThe company makes less than US$1m in revenue. Total revenue: ₹87m (US$989k) This is considered a major risk. Companies with a small amount of revenue are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Share price has been highly volatile over the past 3 months (11% average weekly change). Revenue is less than US$1m (₹87m revenue, or US$989k). Market cap is less than US$10m (₹95.0m market cap, or US$1.09m).
Valuation Update With 7 Day Price Move • Aug 14Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to ₹14.60, the stock trades at a trailing P/E ratio of 42.9x. Average trailing P/E is 26x in the Chemicals industry in India. Total loss to shareholders of 38% over the past three years.
New Risk • Jul 21New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 8.4% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Share price has been highly volatile over the past 3 months (8.4% average weekly change). Market cap is less than US$10m (₹99.9m market cap, or US$1.16m). Minor Risk Revenue is less than US$5m (₹97m revenue, or US$1.1m).
Reported Earnings • Jun 02Full year 2025 earnings released: EPS: ₹0.31 (vs ₹0.76 loss in FY 2024)Full year 2025 results: EPS: ₹0.31 (up from ₹0.76 loss in FY 2024). Revenue: ₹102.8m (down 1.7% from FY 2024). Net income: ₹2.21m (up ₹7.13m from FY 2024). Profit margin: 2.2% (up from net loss in FY 2024). The move to profitability was driven by lower expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 66 percentage points per year, which is a significant difference in performance.
お知らせ • May 17Lime Chemicals Limited to Report Q4, 2025 Results on May 30, 2025Lime Chemicals Limited announced that they will report Q4, 2025 results on May 30, 2025
New Risk • Apr 02New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (6.4% operating cash flow to total debt). Market cap is less than US$10m (₹106.0m market cap, or US$1.24m). Minor Risks Share price has been volatile over the past 3 months (8.8% average weekly change). Revenue is less than US$5m (₹104m revenue, or US$1.2m).
Buy Or Sell Opportunity • Feb 17Now 20% undervalued after recent price dropOver the last 90 days, the stock has fallen 28% to ₹20.00. The fair value is estimated to be ₹25.02, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 16% over the last 3 years. Meanwhile, the company has become profitable.
Reported Earnings • Feb 15Third quarter 2025 earnings released: EPS: ₹0.09 (vs ₹0.11 loss in 3Q 2024)Third quarter 2025 results: EPS: ₹0.09 (up from ₹0.11 loss in 3Q 2024). Revenue: ₹26.5m (up 2.0% from 3Q 2024). Net income: ₹635.0k (up ₹1.28m from 3Q 2024). Profit margin: 2.4% (up from net loss in 3Q 2024). The move to profitability was primarily driven by lower expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 86 percentage points per year, which is a significant difference in performance.
お知らせ • Feb 03Lime Chemicals Limited to Report Q3, 2025 Results on Feb 14, 2025Lime Chemicals Limited announced that they will report Q3, 2025 results on Feb 14, 2025
Buy Or Sell Opportunity • Nov 25Now 23% undervalued after recent price dropOver the last 90 days, the stock has fallen 3.1% to ₹25.55. The fair value is estimated to be ₹32.99, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 14% over the last 3 years. Meanwhile, the company became loss making.
New Risk • Nov 23New major risk - Revenue and earnings growthEarnings have declined by 4.5% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (6.4% operating cash flow to total debt). Share price has been highly volatile over the past 3 months (9.4% average weekly change). Earnings have declined by 4.5% per year over the past 5 years. Market cap is less than US$10m (₹174.9m market cap, or US$2.07m). Minor Risk Revenue is less than US$5m (₹104m revenue, or US$1.2m).
お知らせ • Nov 02Lime Chemicals Limited to Report Q2, 2025 Results on Nov 14, 2024Lime Chemicals Limited announced that they will report Q2, 2025 results on Nov 14, 2024
お知らせ • Aug 30Lime Chemicals Limited, Annual General Meeting, Sep 30, 2024Lime Chemicals Limited, Annual General Meeting, Sep 30, 2024.
Reported Earnings • Aug 15First quarter 2025 earnings released: EPS: ₹0.24 (vs ₹0.33 loss in 1Q 2024)First quarter 2025 results: EPS: ₹0.24 (up from ₹0.33 loss in 1Q 2024). Revenue: ₹30.8m (down 5.2% from 1Q 2024). Net income: ₹1.53m (up ₹3.63m from 1Q 2024). Profit margin: 5.0% (up from net loss in 1Q 2024). The move to profitability was driven by lower expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 90 percentage points per year, which is a significant difference in performance.
お知らせ • Aug 02Lime Chemicals Limited to Report Q1, 2025 Results on Aug 14, 2024Lime Chemicals Limited announced that they will report Q1, 2025 results on Aug 14, 2024
Buy Or Sell Opportunity • Jul 04Now 15% undervaluedThe stock has been flat over the last 90 days, currently trading at ₹29.12. The fair value is estimated to be ₹34.16, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 16% over the last 3 years. Meanwhile, the company became loss making.
Buy Or Sell Opportunity • Jun 19Now 24% undervalued after recent price dropOver the last 90 days, the stock has fallen 9.0% to ₹26.14. The fair value is estimated to be ₹34.28, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 16% over the last 3 years. Meanwhile, the company became loss making.
Buy Or Sell Opportunity • Jun 11Now 22% undervalued after recent price dropOver the last 90 days, the stock has fallen 7.9% to ₹26.26. The fair value is estimated to be ₹33.76, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 16% over the last 3 years. Meanwhile, the company became loss making.
Reported Earnings • Jun 04Full year 2024 earnings released: ₹0.76 loss per share (vs ₹4.24 profit in FY 2023)Full year 2024 results: ₹0.76 loss per share (down from ₹4.24 profit in FY 2023). Revenue: ₹108.5m (down 30% from FY 2023). Net loss: ₹4.92m (down 118% from profit in FY 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 62 percentage points per year, which is a significant difference in performance.
お知らせ • May 20Lime Chemicals Limited to Report Q4, 2024 Results on May 30, 2024Lime Chemicals Limited announced that they will report Q4, 2024 results on May 30, 2024
New Risk • Apr 18New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Market cap is less than US$10m (₹178.2m market cap, or US$2.13m). Minor Risks Share price has been volatile over the past 3 months (8.5% average weekly change). Revenue is less than US$5m (₹115m revenue, or US$1.4m).
Reported Earnings • Feb 16Third quarter 2024 earnings released: ₹0.11 loss per share (vs ₹4.38 profit in 3Q 2023)Third quarter 2024 results: ₹0.11 loss per share (down from ₹4.38 profit in 3Q 2023). Revenue: ₹25.9m (down 30% from 3Q 2023). Net loss: ₹645.0k (down 102% from profit in 3Q 2023). Over the last 3 years on average, earnings per share has fallen by 43% per year but the company’s share price has increased by 15% per year, which means it is well ahead of earnings.
New Risk • Nov 12New major risk - Earnings qualityThe company has a high level of non-cash earnings. Accrual ratio: 88% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Share price has been highly volatile over the past 3 months (11% average weekly change). High level of non-cash earnings (88% accrual ratio). Market cap is less than US$10m (₹172.4m market cap, or US$2.07m). Minor Risk Revenue is less than US$5m (₹126m revenue, or US$1.5m).
Reported Earnings • Nov 12Second quarter 2024 earnings released: ₹0.18 loss per share (vs ₹0.06 loss in 2Q 2023)Second quarter 2024 results: ₹0.18 loss per share (further deteriorated from ₹0.06 loss in 2Q 2023). Revenue: ₹22.9m (down 48% from 2Q 2023). Net loss: ₹1.09m (loss widened 240% from 2Q 2023). Over the last 3 years on average, earnings per share has fallen by 19% per year but the company’s share price has increased by 11% per year, which means it is well ahead of earnings.
お知らせ • Nov 04Lime Chemicals Limited to Report Q2, 2024 Results on Nov 11, 2023Lime Chemicals Limited announced that they will report Q2, 2024 results at 3:30 PM, Indian Standard Time on Nov 11, 2023
Valuation Update With 7 Day Price Move • Oct 05Investor sentiment improves as stock rises 18%After last week's 18% share price gain to ₹27.99, the stock trades at a trailing P/E ratio of 7.4x. Average trailing P/E is 27x in the Chemicals industry in India. Total returns to shareholders of 99% over the past three years.
お知らせ • Sep 07Lime Chemicals Limited, Annual General Meeting, Sep 30, 2023Lime Chemicals Limited, Annual General Meeting, Sep 30, 2023, at 11:30 Indian Standard Time. Location: K Star Hotel, Rajiv Gandhi Road, Sector-11, C.B.D. Belapur (East) Navi Mumbai Maharashtra India Agenda: To receive and adopt the Profit and Loss Account for the year ended on 31st March, 2023 and the Balance Sheet as on that date and the reports of Auditors and Directors thereof; to consider directorate reelections; to appoint statutory auditors of the Company and fix their remuneration; to consider Ratification of remuneration of Cost Auditors; and to consider other matters.
Reported Earnings • Aug 15First quarter 2024 earnings released: ₹0.33 loss per share (vs ₹0.12 profit in 1Q 2023)First quarter 2024 results: ₹0.33 loss per share (down from ₹0.12 profit in 1Q 2023). Revenue: ₹33.5m (down 17% from 1Q 2023). Net loss: ₹2.10m (down 361% from profit in 1Q 2023). Over the last 3 years on average, earnings per share has fallen by 1% per year whereas the company’s share price has remained flat.
お知らせ • Aug 04Lime Chemicals Limited to Report Q1, 2024 Results on Aug 14, 2023Lime Chemicals Limited announced that they will report Q1, 2024 results on Aug 14, 2023
Reported Earnings • Jun 01Full year 2023 earnings released: EPS: ₹4.24 (vs ₹15.06 in FY 2022)Full year 2023 results: EPS: ₹4.24 (down from ₹15.06 in FY 2022). Revenue: ₹156.0m (up 11% from FY 2022). Net income: ₹27.6m (down 72% from FY 2022). Profit margin: 18% (down from 70% in FY 2022). Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has remained flat, which means it is significantly lagging earnings.
Valuation Update With 7 Day Price Move • Apr 05Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₹24.06, the stock trades at a trailing P/E ratio of 8.3x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 59% over the past three years.
お知らせ • Jan 24Lime Chemicals Limited to Report Q3, 2023 Results on Feb 14, 2023Lime Chemicals Limited announced that they will report Q3, 2023 results at 12:15 PM, Indian Standard Time on Feb 14, 2023
お知らせ • Sep 30Lime Chemicals Limited Appoints Pramod N. Manjrekar as Non-Executive Independent Director52nd Annual General Meeting of Lime Chemicals Limited held on 30" September 2022. announced Appointment of Mr. Pramod N. Manjrekar, as non-executive Independent Director.
Reported Earnings • Sep 10Full year 2022 earnings released: EPS: ₹15.06 (vs ₹0.21 in FY 2021)Full year 2022 results: EPS: ₹15.06 (up from ₹0.21 in FY 2021). Revenue: ₹140.6m (down 37% from FY 2021). Net income: ₹98.0m (up ₹96.6m from FY 2021). Profit margin: 70% (up from 0.6% in FY 2021). Over the last 3 years on average, earnings per share has increased by 93% per year but the company’s share price has only increased by 10% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Sep 06Investor sentiment improved over the past weekAfter last week's 17% share price gain to ₹30.90, the stock trades at a trailing P/E ratio of 2.1x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 37% over the past three years.
お知らせ • Aug 18+ 1 more updateLime Chemicals Limited Announces Executive ChangesLime Chemicals Limited announced that on the recommendation of the Nomination & Remuneration Committee, the Board of Directors of the Company at their meeting held August 17, 2022, have approved the appointments of Mr. Amol V. Patil as Chief Financial Officer. Mr. Amol V. Patil, appointed as Chief Financial Officer with effect from August 17, 2022, in place of Mr. Firoj Ladhani, who retired on 16 August 2022. He is a Key Managerial Personnel of the Company pursuant to Section 203 of the Companies Act, 2013. Mr. Amol V. Patil is B.A. & MBA and working with the Company for the past 3 years as Key Accounts Manager. He has experience in managing Customers & Vendors & also handling Accounts Receivable &tracking cash flow and Financials Planning Of the Company.
お知らせ • Aug 05Lime Chemicals Limited to Report Q1, 2023 Results on Aug 13, 2022Lime Chemicals Limited announced that they will report Q1, 2023 results on Aug 13, 2022
お知らせ • Jun 03Lime Chemicals Limited Announces Resignation of Ms. Runel Saxena as Company Secretary/Compliance OfficerLime Chemicals Limited informed that Ms. Runel Saxena, the Company Secretary and Compliance Officer of the Company has resigned from the close of working hours of May 31, 2022. The Company is in the process of appointing new Company Secretary.
Valuation Update With 7 Day Price Move • Mar 10Investor sentiment improved over the past weekAfter last week's 19% share price gain to ₹32.40, the stock trades at a trailing P/E ratio of 2x. Average trailing P/E is 18x in the Chemicals industry in India. Total loss to shareholders of 6.5% over the past three years.
お知らせ • Feb 02Lime Chemicals Limited to Report Q3, 2022 Results on Feb 14, 2022Lime Chemicals Limited announced that they will report Q3, 2022 results on Feb 14, 2022
Valuation Update With 7 Day Price Move • Oct 04Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₹33.25, the stock trades at a trailing P/E ratio of 2x. Average trailing P/E is 19x in the Chemicals industry in India. Total loss to shareholders of 43% over the past three years.
Recent Insider Transactions • Aug 23Non-Executive Non Independent Director recently bought ₹1.6m worth of stockOn the 20th of August, Shahnaz Dawoodani bought around 56k shares on-market at roughly ₹27.89 per share. This was the largest purchase by an insider in the last 3 months. This was the only on-market transaction from insiders over the last 12 months.
Reported Earnings • Aug 18First quarter 2022 earnings released: EPS ₹16.75 (vs ₹0.71 in 1Q 2021)First quarter 2022 results: Revenue: ₹24.2m (down 57% from 1Q 2021). Net income: ₹109.0m (up ₹104.4m from 1Q 2021). Over the last 3 years on average, earnings per share has fallen by 42% per year but the company’s share price has only fallen by 29% per year, which means it has not declined as severely as earnings.
Reported Earnings • Jul 06Full year 2021 earnings released: EPS ₹0.21 (vs ₹0.49 loss in FY 2020)The company reported a decent full year result with improved earnings and profit margins, although revenues were weaker. Full year 2021 results: Revenue: ₹246.2m (down 22% from FY 2020). Net income: ₹1.35m (up ₹4.53m from FY 2020). Profit margin: 0.5% (up from net loss in FY 2020). The move to profitability was driven by lower expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 77 percentage points per year, which is a significant difference in performance.
Valuation Update With 7 Day Price Move • May 28Investor sentiment improved over the past weekAfter last week's 18% share price gain to ₹25.85, the stock trades at a trailing P/E ratio of 11.5x. Average trailing P/E is 20x in the Chemicals industry in India. Total loss to shareholders of 74% over the past three years.
Reported Earnings • Feb 14Third quarter 2021 earnings released: ₹0.04 loss per share (vs ₹0.063 loss in 3Q 2020)The company reported a decent third quarter result with reduced losses and improved control over expenses, although revenues were weaker. Third quarter 2021 results: Revenue: ₹53.6m (down 27% from 3Q 2020). Net loss: ₹244.0k (loss narrowed 41% from 3Q 2020). Over the last 3 years on average, earnings per share has fallen by 98% per year but the company’s share price has only fallen by 34% per year, which means it has not declined as severely as earnings.
お知らせ • Feb 06Lime Chemicals Limited to Report Q3, 2021 Results on Feb 13, 2021Lime Chemicals Limited announced that they will report Q3, 2021 results on Feb 13, 2021
Is New 90 Day High Low • Jan 05New 90-day high: ₹23.55The company is up 67% from its price of ₹14.10 on 07 October 2020. The Indian market is up 20% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 21% over the same period.
Valuation Update With 7 Day Price Move • Dec 21Investor sentiment improved over the past weekAfter last week's 15% share price gain to ₹18.20, the stock is trading at a trailing P/E ratio of 8.2x, up from the previous P/E ratio of 7.1x. This compares to an average P/E of 17x in the Chemicals industry in India. Total return to shareholders over the past three years is a loss of 64%.
お知らせ • Dec 20Lime Chemicals Limited Announces Resignation of Suresh John as 'Non-Executive Independent Director Designated as Chairman of the Board of Directors of the Company with Effect from 19Th December 2020Lime Chemicals Limited announced that Mr. Suresh John has resigned from 'Non-Executive Independent Director designated as Chairman of the Board of Directors of the Company with effect from 19th December 2020.
Is New 90 Day High Low • Oct 23New 90-day high: ₹23.35The company is up 4.0% from its price of ₹22.50 on 24 July 2020. The Indian market is up 7.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 13% over the same period.
